Medical Devices: Page
-
Swiss regulator weighs in on textured breast implants
Swissmedic is the latest national authority to flag a lymphoma that may be tied to breast implants.
By Susan Kelly • Feb. 20, 2019 -
Medtronic and J&J lost spine share to pure-play rivals in Q4, analysts say
Globus Medical, NuVasive and Stryker's K2M drew business away from the medtech giants, mirroring a trend seen the past two years.
By Nick Paul Taylor • Feb. 20, 2019 -
Explore the Trendlineā
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
FDA grants breakthrough status to concussion-detecting VR headset
The SyncThink device analyzes the wearer's eye movements. The medtech has deals with the Golden State Warriors and hospitals including Mass General.
By Nick Paul Taylor • Feb. 20, 2019 -
Medtronic recalls pacemakers due to software error
The medtech giant is recalling 13,440 of the devices in the United States because the defect could result in a break in pacing function.
By Susan Kelly • Feb. 19, 2019 -
FDA clarifies pathway for devices used in regenerative medicine
The final guidance document covers instruments, machines and implants used in conjunction with cell-based and gene therapies.
By Susan Kelly • Feb. 19, 2019 -
FDA proposes new channel for giving feedback on inspections
The agency is looking to create a process for providing nonbinding feedback to medical device companies that it expects to help speed corrective actions on safety and quality issues.
By Susan Kelly • Feb. 19, 2019 -
Medtronic posts beat-and-raise Q3 despite tumbling heart failure sales
Heart failure sales fell more than 40% as Abbott's HeartMate 3 took a big chunk of market share. Separately, the company reported FDA breakthrough designation for its personalized closed loop insulin pump system.
By Nick Paul Taylor • Feb. 19, 2019 -
Deep Dive
4 main takeaways from HIMSS19
Digest the biggest health IT conference of the year with this roundup of what grabbed the attention of more than 43,000 health execs, policymakers and academics.
By David Lim , Rebecca Pifer Parduhn • Feb. 15, 2019 -
FDA orders doctor to stop marketing unapproved breast augmentation device
The warning letter comes amid increased scrutiny of breast implants by regulators globally, with reported cases of adverse events linked to the devices on the rise.
By Susan Kelly • Feb. 15, 2019 -
Boston Scientific-BTG deal faces FTC holdup
The embolization beads businesses are at the heart of U.S. anti-trust regulators' concerns.
By Maria Rachal • Feb. 15, 2019 -
HIMSS19: Doctors don't know what to do with data from wearables
"If you present this data and bring in your device and say 'here I have this heart rate data from the last month' we're going to say, 'that's great, but we don't know what it really means,'" a Mayo Clinic medical director said.
By David Lim • Feb. 15, 2019 -
HIMSS19: Medical device cybersecurity still top concern
The WannaCry attack highlighted the need for hospitals to have a better understanding of medical devices in their inventory in order to better be equipped to respond to cyberattacks.
By David Lim • Feb. 15, 2019 -
New medtech initiatives to be funded amid 9% FDA budget boost
The agency would receive $269 million more in funding this year from the appropriations package that passed Congress, with allocations for initiatives addressing medtech manufacturing and digital health.
By Maria Rachal • Feb. 15, 2019 -
Insulet gains 'ACE' label for interoperable insulin pump, following Tandem
Diabetes tech company Insulet said Monday FDA granted its commercialized Omnipod Dash system clearance as an alternate controller enabled infusion pump.
By Nick Paul Taylor • Updated Sept. 23, 2019 -
HIMSS19: CMS plans to host AI challenge, innovation chief says
The goal of the initiative is to spur private interest in the tech, improve the government's grasp on healthcare data, eliminate unnecessary care and cut costs, Adam Boehler said.
By Rebecca Pifer Parduhn • Feb. 14, 2019 -
Medical devices recalled from US jump in Q4
The more than 400% surge in recalled units was underpinned by a widespread action by BD.
By Nick Paul Taylor • Feb. 14, 2019 -
Software products face high-risk upclassing in Australia
The Therapeutic Goods Administration wants to significantly increase the regulatory burden on medical software, with some products potentially jumping from the lowest to highest risk category.
By Nick Paul Taylor • Feb. 14, 2019 -
Deep Dive
HIMSS19: Private sector catch-up, patient matching and standard APIs dominate first full day
Support for the HHS rules (but some concern over implementation) was the focus at the start of health IT's biggest week.
By Rebecca Pifer Parduhn • Feb. 13, 2019 -
J&J makes $3.4B robotic surgery buy
Johnson & Johnson gets the added boost of Auris Health's CEO and co-founder Frederic Moll joining its team, who notably co-founded market-leading Intuitive Surgical.
By Jacob Bell • Updated Feb. 14, 2019 -
FDA panel backs vaginal mesh option, wants more data
The agency will consider recommendations from the obstetrics and gynecology devices panel as it makes decisions on premarket approval applications from Boston Scientific and Coloplast.
By Maria Rachal • Updated Feb. 14, 2019 -
Edwards Lifesciences buys maker of brain oxygen monitor
The device maker agreed to pay about $100 million for CAS Medical Systems to bolster its position in smart monitoring technologies.
By Susan Kelly • Feb. 13, 2019 -
Breast implants face increased safety scrutiny in Canada
Canada's health regulator is stepping up its review after a spike in reported cases of a form of cancer known as breast implant-associated anaplastic large cell lymphoma, a week after FDA flagged similar issues.
By Susan Kelly • Feb. 13, 2019 -
Device to prevent spinal disc herniation wins PMA after setback
The approval comes more than a year after an FDA advisory panel recommended against clearing the device, citing safety concerns.
By Susan Kelly • Feb. 12, 2019 -
Rapid test for brain injury gets FDA breakthrough status
The test measures protein biomarkers released from the brain into the bloodstream after a head trauma, producing results in as little as 90 seconds.
By Susan Kelly • Feb. 12, 2019 -
FDA approves Orthofix's cervical disc device
The implant will compete with products including Medtronic's Prestige LP and Zimmer Biomet's Mobi-C.
By Nick Paul Taylor • Feb. 12, 2019
Previous
